null Spotlight paper in World Journal of Hepatology: Alshaima Al Hinai
Recognition for former RI-MUHC trainee’s work on nonalcoholic fatty liver disease
Alshaima Al Hinai has earned international recognition for work on nonalcoholic fatty liver disease (NAFLD) in liver transplant recipients. Completed as a trainee at the Research Institute of the McGill University Health Centre (RI-MUHC), her M.Sc. work was published recently in the World Journal of Hepatology and selected for a highlight by the Canadian Donation and Transplantation Research Program (CDTRP). The study, “Non-alcoholic steatohepatitis in liver transplant recipients diagnosed by serum cytokeratin 18 and transient elastography: A prospective study,” was supervised by Dr. Giada Sebastiani of the Infectious Diseases and Immunity in Global Health Program at the RI-MUHC.
“Providing the most accurate diagnosis and the earliest prevention strategies for patients are goals that every physician strives to achieve,” says Alshaima Al Hinai. “As a researcher, my ambition is to study these aspects and contribute to new knowledge to help improve patient care for people living with liver diseases.”
In an interview, she describes how the results will help improve awareness and monitoring in a key group of liver transplant recipients. Read more on the CDRTP website.
Read the paper in World J Hepatol.